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ABSTRACT 
INTRODUCTION 
Cystic disease of the breast has been recognized as the most frequent female 
benign breast lesion.Gross breast cysts filled with serous fluid are almost always 
benign, yet there is four times greater risk of developing a malignancy in the breast.  
The biochemical content of breast cyst fluid (BCF) reflects the endocrine milieu of the 
breast and the study of hormonal content of fluid aspirated from breast cysts has 
yielded a wealth of data that may shed some light on the pathogenesis of benign breast 
disease as it possibly relates to mammary cancer. 
AIMS AND OBJECTIVES 
1. To analyse the expression of β-hCG in patients with benign and malignant 
cystic breast diseases 
2. To assess the usefulness of β-hCG in the diagnosis of benign and 
malignant cystic breast lumps 
MATERIALS AND METHODS 
This is a prospective study done on 50 patients fulfilling the inclusion criteria 
admitted in various surgical wards of Madras medical college & RGGGH, Chennai 
during the period June 2017 to May 2018. The patients fulfilling the inclusion criteria 
are subjected to clinical, radiological & pathological investigations. Breast cystic fluid 
β-hCG levels are estimated and the increase in BCF β-hCG levels in accordance with 
benign and malignant conditions studied. 
RESULTS 
In present study, about 97.4% of the benign cystic breast disease patients had 
increased β-hCG levels (P < .01). 
CONCLUSION 
BCF β-hCG levels are useful in the diagnosis of benign breast cysts and 
increased breast cystic fluid β-hCG levels are favorable towards benign breast cystic 
disease. 
